 |
 |

Mae III Positively Detects the Mitochondrial Mutation Associated With Type I Leber's Hereditary Optic Neuropathy
Edwin M. Stone, MD, PhD;
Jeffrey M. Coppinger;
Randy H. Kardon, MD, PhD;
John Donelson, PhD
Arch Ophthalmol. 1990;108(10):1417-1420.
Abstract
Leber's hereditary optic neuropathy is a blinding disease that usually causes acute or subacute central visual loss in adolescent and young adult males. In patients who lack a family history of a similar illness, Leber's disease has been a diagnosis of exclusion. The recent discovery of a specific mitochondrial mutation in many pedigrees affected with the disease has provided the basis for rapid molecular diagnosis of one genetic type of Leber's disease. We have developed a new method, based on a Mae III (Boehringer Mannheim Biochemicals, Indianapolis, Ind) restriction fragment length polymorphism, for detecting the Wallacetype Leber's mutation. The method has several advantages over the previously used SfaN I method that make it more suitable for use as a general laboratory test. We demonstrate the utility of this new test in the diagnosis of Leber's disease in a patient with no family history of visual loss.
Author Affiliations
From the Departments of Ophthalmology (Drs Stone and Kardon and Mr Coppinger) and Biochemistry (Dr Donelson), The University of Iowa College of Medicine, The Howard Hughes Medical Institute, Iowa City.
Footnotes
Accepted for publication July 26, 1990.
Reprint requests to Department of Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa City, IA 52242 (Dr Stone).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Identical Twins Who Are Discordant for Leber's Hereditary Optic Neuropathy
Johns et al.
Arch Ophthalmol 1993;111:1491-1494.
ABSTRACT
Leber's Hereditary Optic Neuropathy: New Genetic Considerations
Newman
Arch Neurol 1993;50:540-548.
ABSTRACT
Transposed Figures
Arch Ophthalmol 1990;108:1407-1407.
ABSTRACT
|